ADLM announces 2025 Top Corporate Supporter Award recipients
46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits
46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits
First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat
New findings at ADLM 2025 could remedy this failure
Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025
The award recognises Gradientech’s impactful and innovative campaign to raise awareness about its QuickMIC ultra-rapid antibiotic susceptibility testing (AST) system
With a bold new identity and expanded capabilities, HiArc emerges as a next-generation engineering and manufacturing partner for the life science and diagnostics industry
ADLM 2025 studies highlight promising options for cervical and endometrial cancer
Forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging AI-driven clinical decision support market
Key topics included the health effects of plastics, tackling medical misinformation, and advancing clinical care with AI
Roche has been recognized as No. 1 in seven of nine award categories
Scientists propose gene editing to restore lost genetic diversity and rescue endangered species, combining modern biotech with traditional conservation
Laboratories in the Food Chemistry Division selected for elite EU working group
New blood test unveiled developed using artificial intelligence could lead to improved patient outcomes
Researchers identify SDR42E1 as a critical regulator of vitamin D metabolism, revealing its potential as a dual-purpose target for precision therapies
Brain-targeted gene editing improved symptoms and survival rates in mice with the genetic mutations behind alternating hemiplegia of childhood
Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts
This collaboration is working to accelerate development of next-generation basophil activation testing
New range of stages at Microscopy & Microanalysis (M&M) 2025 including Linkam's cryo portfolio, amongst other new developments
Gastrointestinal biomarker tests enhance patient diagnosis of IBD and pancreatic insufficiency on leading clinical chemistry platforms
ADLM 2025, the leading event in clinical diagnostics and lab medicine, takes place July 27–31 in Chicago
Novel nanomaterials may protect against neurological diseases through antioxidant abilities
Expanded high-value end-to-end solution positions business for rapid growth in multi-billion dollar functional GI market
New collaborative study has directly mapped what happens inside liquid crystals when they are deformed
Experienced clinical immunologist and global life science executive to support progression of lead candidate through the clinic